Archives: 2025-10-29

Simple saliva test could revolutionise heart failure detection

Detecting acute heart failure in the future could be as simple as testing a  saliva sample. Australian scientists have developed a biosensor that can rapidly detect the heart failure biomarker S100A7 in saliva,  offering a simple, non-invasive way to identify the disease. The breakthrough, published in Biosensors and Bioelectronics: X could make heart failure screening more accessible,

Read More


Novel Sirolimus-Eluting Balloon Appears Noninferior to Conventional Therapies for Treatment of In-stent Restenosis

Trial led by Mount Sinai researcher could lead to safer and easier treatment for patients with coronary in-stent restenosis A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis (ISR) undergoing repeated percutaneous coronary intervention (PCI). These breakthrough findings of an international clinical trial led by a

Read More


Subretinal Photovoltaic Implant to Restore Vision in Geographic Atrophy Due to AMD

he New England Journal of Medicine (NEJM) today published a peer-reviewed original paper with the results of the landmark clinical trial demonstrating the efficacy of PRIMA brain computer interface (BCI) retinal implant. The paper showed PRIMA restored functional central vision; 80% of patients demonstrated meaningful improvement of visual acuity and were able to read letters, numbers, and words. The

Read More


Low-dose radiation therapy offers substantial relief to people with painful knee osteoarthritis

Placebo-controlled clinical trial finds non-invasive radiation treatment offers a conservative alternative to medications, joint surgery A single course of low-dose radiation therapy may provide a safe and effective alternative treatment option for people with painful knee osteoarthritis according to a new randomized, placebo-controlled clinical trial. The study showed patients with mild to moderate knee osteoarthritis

Read More


FDA Clears Roche’s Elecsys pTau181 Test for Ruling Out Alzheimer-Related Amyloid Pathology

According to a new announcement, the FDA has given clearance to Roche’s Elecsys ptau181 test, marking it the first blood-based biomarker test available for use in primary care settings to assist in Alzheimer disease (AD) assessment and diagnosis. Through this minimally invasive test, clinicians may better identify patients in early stages of cognitive decline who

Read More


Operation performed in Europe for the first time: Brain-computer interface for a patient with quadriplegia

A team at the Technical University of Munich’s TUM University Hospital has implanted a brain-computer interface in a patient paralyzed from the neck down. The five-hour procedure was the first of its kind performed in Europe. The device enables research that could one day help restore independence and improve quality of life for patients. In

Read More